WHO's Covaxin Approval will be Smooth Traveling for Indians: S Jaishankar
WHO on Wednesday granted emergency use approval for Bharat Biotech''s COVID-19 vaccine Covaxin, in a move that the pharma major said is a "significant" step towards ensuring wider global access to the indigenously developed jab.
New Delhi: External Affairs Minister S Jaishankar on Wednesday said the WHO''s decision to grant emergency use approval to Bharat Biotech''s COVID-19 vaccine Covaxin facilitates travel for many Indian citizens and contributes to vaccine equity.
He said it was also a global recognition of Prime Minister Narendra Modi's vision of an ''Atmanirbhar Bharat''.
The World Health Organisation(WHO) on Wednesday granted emergency use approval for Bharat Biotech''s COVID-19 vaccine Covaxin, in a move that the pharma major said is a "significant" step towards ensuring wider global access to the indigenously developed jab.
"Welcome @WHO's decision to grant Emergency Use Listing to #COVAXIN. It facilitates travel for many Indian citizens and contributes to vaccine equity. Also a global recognition to PM @narendramodi's vision of an #AtmanirbharBharat. A Happier Diwali," Mr Jaishankar tweeted.
Original News : All India | Press Trust of India
( Except for the headline, this story has not been edited by Scrabbl staff and is published from a syndicated feed.)